Concerning the activated CD8+ T cell population expressing CD38 and HLA-DR, the levels were elevated compared to healthy controls and were sustained for more than 6 weeks, whereas the CD4+ T cells decreased over time within the COVID-19 patients. The gene discussed is CD8A; the disease is COVID-19.